GEN Magazine Volume 44, Issue No. 6, June 2024 Website Content From This Issue Website Content from This IssueInsightsMultiomic Mosaics Cell by Cell, Pixel by PixelJune 1, 2024InsightsMultiomics Couples Data Generation and Clinical ScienceJune 1, 2024Drug DiscoveryMicrobiome Therapeutics: Out of Range or Just Under the Radar?June 1, 2024Artificial IntelligenceAI Emboldens the Exploration of Target SpaceJune 1, 2024Genome EditingCRISPR 2.0: Kinder, Gentler, More Powerful Gene EditingJune 1, 2024BioprocessingUpstream Bioprocessing: Virtual Bioreactors Get RealJune 1, 2024BioprocessingUpstream Bioprocessing: More Intense and More StableJune 1, 2024Artificial IntelligenceAI Isn’t the Magic Bullet to Simplify Drug DiscoveryJune 1, 2024Drug DiscoveryFinding “Impossible” Antibodies in the Human BodyJune 1, 2024Drug DiscoveryEvolving Trends in PharmaceuticalsJune 1, 2024SponsoredMitigating Risks in Oligonucleotide Therapeutic DevelopmentJune 1, 2024SponsoredAccelerating the Search for Therapeutic AntibodiesJune 1, 2024Artificial IntelligenceSimple, Scalable Absolute Concentrations in Untargeted MetabolomicsJune 1, 2024Drug DiscoveryGet to Your Data Faster: Overcoming Challenges in Spatial BiologyJune 1, 2024BioprocessingComputer-Aided Design for BiologyJune 1, 2024OMICsMultiomics Opens the Door: More Data, More Insight into Biology’s ComplexityJune 1, 2024BioprocessingIncreased Transfection Efficiency Boosts AAV Titers for Gene Therapies by 2–4XJune 1, 2024New ProductsMicrospectral Analysis SafetyJune 1, 2024New ProductsSpectral Flow Cytometry SolutionJune 1, 2024Artificial IntelligenceAdvance Multimodal Therapeutics with Multimodal Entity Registration SoftwareJune 1, 2024New ProductsAutomated Gel StainingJune 1, 2024New ProductsTOC AnalyzerJune 1, 2024New ProductsDigital Liquid Flow SensorJune 1, 2024New ProductsNGS Panel for Acute Myeloid LeukemiaJune 1, 2024A-ListsTop 10 Publicly Owned Gene Editing Therapy CompaniesMay 31, 2024A-ListsTop Five Privately Held Gene Editing Therapy CompaniesMay 31, 2024Drug DiscoveryBoy Dosed with Pfizer DMD Gene Therapy Dies a Year after Phase II TrialMay 7, 2024Genome EditingCRISPR Enzyme Found in Metagenomic Study Is Tiny, Yet Active and PreciseMay 6, 2024CancerCancer Vaccine Tested in Glioblastoma Patients Shows Potential of mRNA AggregatesMay 1, 2024Drug DiscoveryFDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia BApril 28, 2024Artificial IntelligenceAI Drug Developer Xaira Therapeutics Launches with $1B+April 25, 2024GEN EdgeRegeneron, Mammoth Launch In Vivo CRISPR Gene Editing CollaborationApril 25, 2024